{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T06:46:16Z","timestamp":1792478776425,"version":"4.5.0"},"reference-count":113,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":510,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,8]]},"abstract":"<jats:p>Proton pump inhibitors have dramatically influenced the management of acid\u2010peptic disorders in recent years. They all have a broadly similar mechanism of action and are extensively metabolized in the liver via cytochromes P450 2C19 and 3A4. There is some variation in their potential for drug interactions due to differences in enzyme inhibition. Relatively few serious adverse effects have been reported for the proton pump inhibitors.<\/jats:p><jats:p>Comparative studies of acid suppression suggest that lansoprazole and pantoprazole have a potency similar to that of omeprazole on a mg for mg basis; however, rabeprazole may have a greater potency than omeprazole. Lansoprazole and rabeprazole display a more rapid onset of maximal acid suppression than the other proton pump inhibitors.<\/jats:p><jats:p>Comparative studies using proton pump inhibitors for the treatment of reflux oesophagitis, duodenal ulcer healing and <jats:italic>Helicobacter pylori<\/jats:italic> eradication show little overall difference in outcome between the proton pump inhibitors when used in their standard doses. Lansoprazole and rabeprazole provide earlier and better symptom relief than the other proton pump inhibitors in some studies of peptic ulcer treatment. The few studies of gastric ulcer treatment suggest that there is an advantage in using the proton pump inhibitors that have a higher standard daily dose.<\/jats:p>","DOI":"10.1046\/j.1365-2036.2000.00788.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:41:50Z","timestamp":1047354110000},"page":"963-978","source":"Crossref","is-referenced-by-count":258,"title":["Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors"],"prefix":"10.1111","volume":"14","author":[{"given":"C. A. M.","family":"Stedman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Barclay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.pa.35.040195.001425"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00394.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1993.tb00582.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199855020-00009"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00418.x"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199610001-00004"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1990.tb03679.x"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199528060-00004"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.272.36.22438"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199703000-00003"},{"key":"e_1_2_7_12_2","first-page":"185","article-title":"Pharmacokinetics of pantoprazole in man","volume":"34","author":"Huber R","year":"1996","journal-title":"Int J Clin Pharmacol Therapeut"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199448030-00007"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050111"},{"key":"e_1_2_7_15_2","first-page":"A165","article-title":"Dose\u2013response of pantoprazole 20, 40 and 80\u2003mg on 24\u2013hour intragastric pH, serum pantoprazole and serum gastrin in man","volume":"106","author":"Reill L","year":"1994","journal-title":"Gastroenterology"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00225.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/53.12.1401"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018891106425"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199631010-00002"},{"key":"e_1_2_7_20_2","first-page":"S31","article-title":"Lack of pantoprazole drug interactions in man: an updated review","volume":"34","author":"Steinijans VW","year":"1996","journal-title":"Int J Clin Pharmacol Therapeut"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00265957"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1986.186"},{"key":"e_1_2_7_23_2","first-page":"A126","article-title":"Pharmacokinetics of the proton pump inhibitor pantoprazole in patients with severe renal impairment","volume":"106","author":"Lins RL","year":"1994","journal-title":"Gastroenterology"},{"key":"e_1_2_7_24_2","first-page":"A90","article-title":"Comparative kinetic studies with the three proton pump inhibitors omeprazole, lansoprazole and pantoprazole in patients with complete liver cirrhosis","volume":"110","author":"Danz\u2010Neeff H","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-2918(00)88320-4"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1993.tb00398.x"},{"key":"e_1_2_7_27_2","first-page":"A77","article-title":"Pantoprazole in the elderly: no dose\u2010adjustment","volume":"35","author":"Breuel HP","year":"1994","journal-title":"Gut"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-199007000-00020"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.1996.49"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00233.x"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199716030-00003"},{"key":"e_1_2_7_32_2","first-page":"203","article-title":"Interaction of proton pump inhibitors with cytochrome P450: consequences for drug interactions","volume":"69","author":"Meyer UA","year":"1996","journal-title":"Yale J Biol Med"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1993.tb00410.x"},{"key":"e_1_2_7_34_2","first-page":"156P","article-title":"Major implication of cytochrome P4503A4 in the oxidative metabolism of the antisecretory drugs omeprazole and lansoprazole in human liver microsomes and hepatocytes","volume":"36","author":"Curi\u2010Pedrosa R","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_2_7_35_2","first-page":"129","article-title":"BY 1023\/SK & F 96022 INN pantoprazole, a novel gastric proton pump inhibitor, potently inhibits acid secretion but lacks relevant cytochrome P450 interactions","volume":"254","author":"Kromer S","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(91)90722-H"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199610001-00005"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00194956"},{"key":"e_1_2_7_39_2","first-page":"A75","article-title":"Lack of effect of concomitant lansoprazole on steady\u2010state theophylline pharmacokinetics","volume":"100","author":"Granneman G","year":"1991","journal-title":"Gastroenterology"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1994.49"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050055"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.126"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(91)90719-2"},{"key":"e_1_2_7_44_2","first-page":"A138","article-title":"Coadministration of rabeprazole sodium (E3810) does not effect the pharmacokinetics of anhydrous theophylline or warfarin","volume":"110","author":"Humphries TJ","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(85)90638-9"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1987.tb03209.x"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1992.172"},{"key":"e_1_2_7_48_2","first-page":"385","article-title":"Lack of pantoprazole drug interactions in man","volume":"32","author":"Steinijans VW","year":"1994","journal-title":"Int J Clin Pharmacol Ther"},{"key":"e_1_2_7_49_2","first-page":"A77","article-title":"Lack of interaction of pantoprazole and diazepam in man","volume":"102","author":"Gugler R","year":"1992","journal-title":"Gastroenterology"},{"key":"e_1_2_7_50_2","first-page":"1914","article-title":"Rabeprazole sodium (E3810), 20\u2003mg daily does not affect the pharmacokinetics of phenytoin sodium in normal volunteers","volume":"91","author":"Humphries TJ","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1991.tb03953.x"},{"key":"e_1_2_7_52_2","first-page":"1914","article-title":"Coadministration of rabeprazole sodium (E3810) and digoxin results in a predictable interaction","volume":"91","author":"Humphries TJ","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_53_2","first-page":"A138","article-title":"Coadministration of rabeprazole sodium (E3810) and ketoconazole results in a predictable interaction with ketoconazole","volume":"110","author":"Humphries TJ","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_7_54_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200917"},{"key":"e_1_2_7_55_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00293.x"},{"key":"e_1_2_7_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(97)80053-7"},{"key":"e_1_2_7_57_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409094889"},{"key":"e_1_2_7_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00304.x"},{"key":"e_1_2_7_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)23522-1"},{"key":"e_1_2_7_60_2","first-page":"489","article-title":"Effect of four lansoprazole dose levels and one dosage regimen of omeprazole on 24\u2010hour intragastric pH in healthy subjects","volume":"17","author":"Timmer W","year":"1995","journal-title":"Meth Find Exp Clin Pharmacol"},{"key":"e_1_2_7_61_2","first-page":"S2","article-title":"Comparison of pantoprazole (40\u2003mg SID) versus omeprazole (40\u2003mg SID) on intragastric pH and serum gastrin in healthy volunteers","volume":"11","author":"Brunner G","year":"1997","journal-title":"Can J Gastroenterol"},{"key":"e_1_2_7_62_2","first-page":"A79","article-title":"Comparison of 24\u2010h intragastric pH and 24\u2010h gastrin profiles during therapy with the proton pump inhibitors pantoprazole and omeprazole","volume":"35","author":"Koop H","year":"1994","journal-title":"Gut"},{"key":"e_1_2_7_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0953-0673.1996.00359.x"},{"key":"e_1_2_7_64_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199702000-00017"},{"key":"e_1_2_7_65_2","first-page":"915","article-title":"Comparison of the effects of lansoprazole, omeprazole and pantoprazole on 24\u2010hour gastric pH in healthy males","volume":"85","author":"Scholtz HE","year":"1995","journal-title":"SA Med J"},{"key":"e_1_2_7_66_2","first-page":"171","article-title":"Lansoprazole versus omeprazole in the treatment of reflux esophagitis","volume":"51","author":"Vcev A","year":"1997","journal-title":"Acta Med Croatica"},{"key":"e_1_2_7_67_2","first-page":"1749","article-title":"Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis","volume":"91","author":"Castell DO","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_7_68_2","first-page":"A58","article-title":"Lansoprazole in acute treatment of reflux esophagitis","volume":"104","author":"Corallo J","year":"1993","journal-title":"Gastroenterology"},{"key":"e_1_2_7_69_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529309096076"},{"key":"e_1_2_7_70_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.56198000.x"},{"key":"e_1_2_7_71_2","first-page":"306","article-title":"Reflux esophagitis: a comparative study of lansoprazole and omeprazole as short\u2010term therapy. Preliminary report","volume":"61","author":"Cordova\u2010Villabos JA","year":"1996","journal-title":"Revista Gastroenterol Mexico"},{"key":"e_1_2_7_72_2","first-page":"131","article-title":"Clinical effect of proton pump inhibitors on oesophagitis [in Japanese]","volume":"50","author":"Sekiguchi T","year":"1992","journal-title":"Nipp Rinsho"},{"key":"e_1_2_7_73_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199611000-00013"},{"key":"e_1_2_7_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00437.x"},{"key":"e_1_2_7_75_2","first-page":"A136","article-title":"Pantoprazole vs omeprazole in acute reflux esophagitis","volume":"110","author":"Hotz J","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_7_76_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00388.x"},{"key":"e_1_2_7_77_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00438.x"},{"key":"e_1_2_7_78_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00379.x"},{"key":"e_1_2_7_79_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00278.x"},{"key":"e_1_2_7_80_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199412000-00012"},{"key":"e_1_2_7_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00346.x"},{"key":"e_1_2_7_82_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00373.x"},{"key":"e_1_2_7_83_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.1995.tb01352.x"},{"key":"e_1_2_7_84_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0149-2918(99)80033-2"},{"key":"e_1_2_7_85_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529509093265"},{"key":"e_1_2_7_86_2","first-page":"334","article-title":"Comparison of lansoprazole (30\u2003mg) and omeprazole (20\u2003mg) in the treatment of duodenal ulcer","volume":"17","author":"Petite J\u2010P","year":"1993","journal-title":"Gastroenterol Clin Biol"},{"key":"e_1_2_7_87_2","first-page":"777","article-title":"Lansoprazole versus omeprazole in duodenal ulcer healing","volume":"83","author":"Louw JA","year":"1993","journal-title":"Safr Med J"},{"key":"e_1_2_7_88_2","first-page":"407","article-title":"Double\u2010blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer","volume":"7","author":"Beker JA","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_7_89_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00399.x"},{"key":"e_1_2_7_90_2","first-page":"271","article-title":"Efficacy and tolerability of pantoprazole vs omeprazole in the treatment of duodenal ulcer","volume":"7","author":"Italian Group for the Study of Pantoprazole","year":"1994","journal-title":"Argoment Gastroenterol Clin"},{"key":"e_1_2_7_91_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00449.x"},{"key":"e_1_2_7_92_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199800001-00027"},{"key":"e_1_2_7_93_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199754030-00010"},{"key":"e_1_2_7_94_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00405.x"},{"key":"e_1_2_7_95_2","first-page":"A202","article-title":"One week low dose triple therapies with lansoprazole or omeprazole are equally effective for H pylori eradication and ulcer healing","volume":"110","author":"Mullhaupt B","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_7_96_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00319.x"},{"key":"e_1_2_7_97_2","first-page":"A32","article-title":"Omeprazole vs. two different doses of lansoprazole in triple therapy on H. pylori positive duodenal ulcer","volume":"39","author":"Catalano F","year":"1996","journal-title":"Gut"},{"key":"e_1_2_7_98_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00462.x"},{"key":"e_1_2_7_99_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00526.x"},{"key":"e_1_2_7_100_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00455.x"},{"key":"e_1_2_7_101_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199448010-00008"},{"key":"e_1_2_7_102_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199651030-00012"},{"key":"e_1_2_7_103_2","doi-asserted-by":"publisher","DOI":"10.1097\/00063110-199812000-00016"},{"key":"e_1_2_7_104_2","first-page":"599","article-title":"Lansoprazole\u2010induced hepatitis [in Spanish]","volume":"108","author":"Viana de Miguel C","year":"1997","journal-title":"Med Clin (Barc)"},{"key":"e_1_2_7_105_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199709000-00011"},{"key":"e_1_2_7_106_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.314.7097.1805"},{"key":"e_1_2_7_107_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7124.67"},{"key":"e_1_2_7_108_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1996.40211.x"},{"key":"e_1_2_7_109_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1994.tb00239.x"},{"key":"e_1_2_7_110_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00750.x"},{"key":"e_1_2_7_111_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00681.x"},{"key":"e_1_2_7_112_2","first-page":"466","article-title":"Pharmacokinetic properties of E3810, a new proton pump inhibitor, in healthy male volunteers","volume":"32","author":"Yasuda S","year":"1994","journal-title":"Int J Clin Pharmacol Ther"},{"key":"e_1_2_7_113_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1996.03563.x"},{"key":"e_1_2_7_114_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.157332000.x"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00788.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00788.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00788.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T14:02:37Z","timestamp":1698588157000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00788.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":113,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00788.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00788.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}